[Immunology of malignant melanoma].
D000912:Antibodies, Neoplasm / Q000032:analysis; D000917:Antibody Formation; D000951:Antigens, Neoplasm / Q000032:analysis; D001324:Autoantigens / Q000032:analysis; D003429:Cross Reactions; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000276:immunology; D006969:Hypersensitivity, Immediate / Q000276:immunology; D007108:Immune Tolerance; D007114:Immunization; D007153:Immunologic Deficiency Syndromes / Q000276:immunology; D007165:Immunosuppression Therapy; D008545:Melanoma / Q000276:immunology* / Q000628:therapy; D012878:Skin Neoplasms / Q000276:immunology* / Q000628:therapy; D012882:Skin Tests
D000912:Antibodies, Neoplasm; D000951:Antigens, Neoplasm; D001324:Autoantigens
Zur Immunologie des Melanomalignoms